Myriad Genetics
- In Vitro and In Vivo Diagnostic Substances
- Salt Lake City, Utah
Compensation history
Top executives at Myriad Genetics received an average of $4M per person in annual compensation from 2007 to 2019.
Average pay of disclosed executives at Myriad Genetics
By year
- 2019
MC$9MMark C. CaponePresident and Chief Executive Officer and DirectorAF$3MAlexander FordPresident, Myriad Genetic LaboratoriesRR$3MR. Bryan RiggsbeeChief Financial Officer and TreasurerJL$3MJerry S. LanchburyChief Scientific OfficerRM$3MRichard M. MarshExecutive Vice President, General Counsel and Secretary
Executives
We found 12 executives who work or worked at Myriad Genetics.
Mark Capone
Myriad Genetics
Chief Executive Officer
Alexander Ford
Myriad Genetics
President, Myriad Genetic Laboratories
R Riggsbee
Myriad Genetics
Chief Financial Officer
Jerry Lanchbury
Myriad Genetics
Chief Scientific Officer
Richard Marsh
Myriad Genetics
General Counsel
Bernard Tobin
Myriad Genetics
President, Crescendo Bioscience, Inc
Peter Meldrum
Myriad Genetics
Chief Executive Officer
James Evans
Myriad Genetics
Chief Financial Officer
News
About Myriad Genetics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryIn Vitro and In Vivo Diagnostic Substances
- Address320 Wakara Way, Salt Lake City, Utah 84108
- Phone801-584-3600
- Fiscal year endJune 30
Source: SEC filings on October 16, 2019, October 10, 2018, October 12, 2017, October 15, 2015, October 14, 2014, October 15, 2013, October 12, 2012, October 11, 2011, and October 15, 2007.